All details for Asston Pharmaceuticals IPO: Dates, price, subscription, financials, objectives, KPIs, registrar, and company overview.
Bidding: July 9 – July 11, 2025 | Price Band: ₹115–123 | Min 2 lots (₹2,46,000)
Asston Pharmaceuticals IPO: At a Glance
IPO Timeline
| IPO Activity | Date |
|---|---|
| IPO Open Date | July 9, 2025 |
| IPO Close Date | July 11, 2025 |
| Basis of Allotment | July 14, 2025 |
| Refunds Initiation | July 15, 2025 |
| Credit of Shares to Demat | July 15, 2025 |
| IPO Listing Date | July 16, 2025 |
IPO Price & Lot Size
| Issue Price Band | ₹115 – ₹123 per share |
|---|---|
| Market Lot | 1,000 Shares |
| Retail Min | 2 lots (2,000 shares) – ₹2,46,000 |
| Retail Max | 2 lots (2,000 shares) – ₹2,46,000 |
| S-HNI Min | 3 lots (3,000 shares) – ₹3,69,000 |
| S-HNI Max | 8 lots (8,000 shares) – ₹9,84,000 |
| B-HNI Min | 9 lots (9,000 shares) – ₹11,07,000 |
Company Financials (â‚ą Crore)
Bar Chart: Revenue, PAT & Net Worth
Line Chart: Revenue, PAT & Net Worth
| Period Ended | Assets | Revenue | Profit After Tax | EBITDA | Net Worth | Reserves & Surplus | Total Borrowing |
|---|---|---|---|---|---|---|---|
| 31 May 2025 | 31.83 | 6.21 | 1.32 | 1.93 | 12.04 | 5.77 | 7.83 |
| 31 Mar 2025 | 28.12 | 25.61 | 4.33 | 6.16 | 10.72 | 4.45 | 7.26 |
| 31 Mar 2024 | 20.26 | 15.84 | 1.36 | 2.55 | 6.39 | 5.61 | 6.82 |
| 31 Mar 2023 | 13.69 | 7.19 | 1.06 | 1.52 | 1.99 | 1.29 | 5.25 |
Key Performance Indicators (KPI)
| KPI | Values |
|---|---|
| Market Cap | â‚ą104.70 Cr |
| ROE | 50.56% |
| ROCE | 51.25% |
| Debt/Equity | 0.68 |
| RoNW | 40.36% |
| PAT Margin | 17.27% |
| EBITDA Margin | 24.60% |
| Price to Book Value | 12.07 |
| EPS (Pre IPO) | 6.90 |
| EPS (Post IPO) | 9.32 |
| P/E (Pre IPO) | 17.83 |
| P/E (Post IPO) | 13.2 |
Objects of the Issue
| S.No. | Objects | Expected Amount (â‚ą Million) |
|---|---|---|
| 1 | Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit | 60 |
| 2 | Funding the incremental working capital requirements of the Company | 130 |
| 3 | Repayment and/or prepayment, in part or full, of certain of the outstanding borrowings availed by the Company | 10 |
| 4 | General Corporate Purposes | — |
About Asston Pharmaceuticals Limited
Incorporated: 2019
Business: Pharma manufacturing & global exports (tablets, capsules, sachets, syrups — analgesics, antibiotics, antifungals, vitamins, more).
Model: Direct sales, contract/loan licensing, principle-to-principle manufacturing.
Certifications: Central & State FDA, NQA, QMS-compliant.
Products: Albendazole, Diclofenac, Ibuprofen, Paracetamol, Ferrovit syrup, etc.
Employees: 46 permanent + 6 contractual (as of July 2025)
Promoters: Dr. Ashish Narayan Sakalkar, Saili Jayaram More, Sachin Chandrakant Badakh
Strengths:
- Formulation expertise
- Experienced promoters
- Diversified product range
- Strategic location & skilled workforce
Contact Details
4th Floor, Office No. A-431 Balaji Bhavan,
Plot No 42A Sector-11 CBD Belapur,
Navi Mumbai, Thane, Maharashtra, 400614
Phone: +91 22 49731411
Email: info@asstonpharmaceuticals.com
Website: https://asstonpharmaceuticals.com/
